Osteonecrosis fears alleviated

GPs can reassure patients taking bisphosphonates for osteoporosis that they will not have to stop treatment when undergoing dental surgery.

Recent reports of cases of osteonecrosis of the jaw (ONJ) in patients taking bisphosphonates had raised concerns that the drugs were not safe to take if undergoing dental surgery.

However, the European Calcified Tissue Society professional practice committee said that, for patients with osteoporosis treated with bisphosphonates at the licensed dose, the risk of ONJ is very low and the benefits of continuing therapy will outweigh the risk of osteonecrosis.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus